Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra L Quittner

Showing results (161-170 of 168) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 168 results.
The Lancet. Respiratory Medicine|May 8, 2020
Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia (BESTCILIA): a multicentre, double-blind, randomised, placebo-controlled phase 3 trialHelene E Kobbernagel, Frederik F Buchvald, Eric G Haarman, et al.
The European Respiratory Journal|December 15, 2015
An international registry for primary ciliary dyskinesiaClaudius Werner, Martin Lablans, Maximilian Ataian, et al.
The Lancet. Respiratory Medicine|August 26, 2014
Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trialsAlan F Barker, Anne E O'Donnell, Patrick Flume, et al.
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia|June 18, 2025
Depression and anxiety in adolescents with cystic fibrosis in Brazil: prevalence, stability over time, and relationship with treatment adherenceTatiana Rozov, Marcos Tadeu Nolasco da Silva, Maria Ângela Gonçalves Oliveira Ribeiro, et al.
Proceedings of the American Thoracic Society|December 17, 2009
Lung transplantation for cystic fibrosisFrederick R Adler, Paul Aurora, David H Barker, et al.
BMC Medical Research Methodology|April 28, 2019
Prospective multicenter randomized patient recruitment and sample collection to enable future measurements of sputum biomarkers of inflammation in an observational study of cystic fibrosisTheodore G Liou, Frederick R Adler, Natalia Argel, et al.
Iscience|February 22, 2024
Airway inflammation accelerates pulmonary exacerbations in cystic fibrosisTheodore G Liou, Natalia Argel, Fadi Asfour, et al.
The Lancet. Respiratory Medicine|July 8, 2015
Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trialEric W F W Alton, David K Armstrong, Deborah Ashby, et al.
Pageof 17

Showing results (161-170 of 168) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 168 results.
The Lancet. Respiratory Medicine|May 8, 2020
Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia (BESTCILIA): a multicentre, double-blind, randomised, placebo-controlled phase 3 trialHelene E Kobbernagel, Frederik F Buchvald, Eric G Haarman, et al.
The European Respiratory Journal|December 15, 2015
An international registry for primary ciliary dyskinesiaClaudius Werner, Martin Lablans, Maximilian Ataian, et al.
The Lancet. Respiratory Medicine|August 26, 2014
Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trialsAlan F Barker, Anne E O'Donnell, Patrick Flume, et al.
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia|June 18, 2025
Depression and anxiety in adolescents with cystic fibrosis in Brazil: prevalence, stability over time, and relationship with treatment adherenceTatiana Rozov, Marcos Tadeu Nolasco da Silva, Maria Ângela Gonçalves Oliveira Ribeiro, et al.
Proceedings of the American Thoracic Society|December 17, 2009
Lung transplantation for cystic fibrosisFrederick R Adler, Paul Aurora, David H Barker, et al.
BMC Medical Research Methodology|April 28, 2019
Prospective multicenter randomized patient recruitment and sample collection to enable future measurements of sputum biomarkers of inflammation in an observational study of cystic fibrosisTheodore G Liou, Frederick R Adler, Natalia Argel, et al.
Iscience|February 22, 2024
Airway inflammation accelerates pulmonary exacerbations in cystic fibrosisTheodore G Liou, Natalia Argel, Fadi Asfour, et al.
The Lancet. Respiratory Medicine|July 8, 2015
Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trialEric W F W Alton, David K Armstrong, Deborah Ashby, et al.
Pageof 17